||The Association of the British Pharmaceutical Industry (ABPI) represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK. The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry for statutory consultation requirements including the pricing scheme for medicines in the UK. We maintain close contacts with Government, politicians, academia and the media and we also have extensive links with health managers, patient advocacy groups, training and education bodies, research councils and other professional bodies in the healthcare field.
The ABPI supports research using animals where alternative methods are not available, where the potential benefits to health are compelling, and where acceptable ethical and welfare standards can be met. We believe the European Directive 2010/63/EU has enhanced animal welfare standards and introduced the concepts of refinement, replacement and reduction across the EU, while ensuring Europe remains a world leader in biomedical research.